RecruitingNCT00900419

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Biomarkers and Dysplastic Respiratory Epithelium


Sponsor

University of Colorado, Denver

Enrollment

700 participants

Start Date

May 3, 2001

Study Type

OBSERVATIONAL

Conditions

Summary

RATIONALE: Studying samples of sputum and tissue in the laboratory from patients with dysplasia or cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This laboratory study is looking at biomarkers in patients with respiratory tract dysplasia or lung cancer, head and neck cancer, or aerodigestive tract cancer.


Eligibility

Min Age: 21 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting airway tissue samples during bronchoscopy (a procedure to look inside the airways) to find early biological signals that predict whether pre-cancerous airway changes will progress to lung cancer. **You may be eligible if...** - You have been diagnosed with severe or extensive pre-cancerous changes in your airway lining - You have survived a head and neck or lung cancer for at least 1 year - You are undergoing a bronchoscopy for suspected lung cancer, staging, surveillance, or monitoring - You do not have asthma or active lung disease - You have not had a respiratory illness in the past 2 weeks **You may NOT be eligible if...** - You have a bleeding disorder or are on blood thinners - You have active or unstable heart disease (angina, recent heart attack within 6 weeks, serious heart rhythm problems) - You have serious lung problems preventing safe bronchoscopy - You have had acute bronchitis or pneumonia in the last 8 weeks (unless caused by lung cancer) - Your blood oxygen level is too low (below 90%) even with supplemental oxygen Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERimmunohistochemistry staining method

Laboratory test

OTHERlaboratory biomarker analysis

Laboratory Test

OTHERsputum cytology

Laboratory Test

PROCEDUREbiopsy

Laboratory Test


Locations(1)

University of Colorado Cancer Center at UC Health Sciences Center

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00900419


Related Trials